A prospective cohort study.
To evaluate the effects of epidural steroid injections (ESIs) on blood glucose levels in patients with diabetes mellitus.
ESIs are commonly used in the treatment of multiple spinal disorders. Corticosteroid injections have been evaluated in the total joints and hand literature showing systemic effects to diabetics.
Diabetic patients who were scheduled for an ESI were given an opportunity to enroll in our IRB-approved study. We collected the patient's most recent hemoglobin A1c (hA1c) and then asked them to track their blood glucose numbers at least twice per day for 2 weeks prior to and after their ESIs.
We noted a statistically significant increase in blood glucose levels in diabetic patients (n = 30) after ESI. The mean blood glucose level prior to ESI was 160.18 ± 47.46, and, after ESI, it was 286.13 ± 111.11. This represents an average 125.96 ± 100.97 increase in blood glucose levels after injection. Using a nonlinear mixed effect model, the estimated half-life of this increase was 1.06 days (95% CI 0.80, 1.58), meaning that the patients were back within their normal standard deviation mean glucose levels within 2 days of injection. There was no association between observed glucose level change and preinjection hA1c levels or age (Spearman = 0.0326 and −0.1091 separately), indicating that there is no correlation between preinjection hA1c levels and systemic response to ESI.
ESIs were noted to cause a significant increase in the blood glucose levels in diabetics. There was no correlation between preinjection diabetic control, represented by hA1c levels, and postinjection response. Diabetics who are candidates for ESI should be counseled that a blood glucose increase may be apparent post intervention, but effects should not last longer than approximately 2 days.
Epidural steroid injections (ESIs) cause a significant increase in the blood glucose levels in diabetics. There is no correlation between preinjection diabetic control and postinjection response. Diabetics should be counseled that after ESIs their blood glucose may increase but should be at baseline within 48 hours.
From Vanderbilt University Medical Center, Nashville, TN.
Address correspondence and reprint requests to Clinton J. Devin, MD, Vanderbilt University Medical Center, 1215 21st Avenue, MCE South Tower, Suite 4200, Nashville, TN 37232; E-mail: email@example.com
Acknowledgment date: January 27, 2011. First revision date: March 30, 2011. Acceptance date: April 4, 2011.
The manuscript submitted does not contain information about medical device(s)/drug(s).
No funds were received in support of this work. No benefits in any form have been or will be received from a commercial party related directly or indirectly to the subject of this manuscript.